Antibiotic treatment of tuboovarian abscess

Comparison of broad-spectrum β-lactam agents versus clindamycin-containing regimens

Susan D. Reed, Daniel V. Landers, Richard L Sweet

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

One hundred nineteen patients with tuboovarian abscess were evaluated for response to antibiotics. Results were stratified into three groups by antimicrobial regimen. Group 1 consisted of 37 patients treated with a single-agent broad-spectrum intravenous antibiotic and oral doxycycline. Initial clinical response (defined as decreased pain, diminished white blood cell count, or defervescence) in group 1 was 31/37 (84%). Group 2 consisted of 64 patients treated with clindamycin in combination with an aminoglycoside with or without a penicillin. There was an initial clinical response in 45 of 64 (70%). Group 3 consisted of 18 patients from group 1 who were changed to a clindamycin-containing regimen after 2 to 3 days of initial treatment with a single-agent broad-spectrum antibiotic. The decision to switch antibiotics was not based on treatment failure but occurred when delayed ultrasonography confirmed the diagnosis of tuboovarian abscess. The switch reflected physician preference for clindamycin-containing regimens in the treatment of tuboovarian abscesses. The response rate in this subset of patients was 14 of 18 (78%). Overall initial clinical response rate was 90 of 119 (75%). There were no statistically significant demographic or clinical differences among the three groups. There was no statistical difference in the rate of early and late antibiotic failure rates among the groups. Our study demonstrates that extended-spectrum antibiotic coverage, including single-agent broad-spectrum antibiotics such as cefoxitin, in conjunction with doxycycline has efficacy that is equivalent to that of clindamycin-containing regimens. An overall medical treatment success rate of 75% suggests that conservative treatment of tuboovarlan abscesses is warranted.

Original languageEnglish (US)
Pages (from-to)1556-1562
Number of pages7
JournalAmerican Journal of Obstetrics and Gynecology
Volume164
Issue number6 PART 1
DOIs
StatePublished - 1991

Fingerprint

Lactams
Clindamycin
Abscess
Anti-Bacterial Agents
Doxycycline
Therapeutics
Cefoxitin
Aminoglycosides
Treatment Failure
Leukocyte Count
Penicillins
Ultrasonography
Demography
Physicians
Pain

Keywords

  • antimicrobial therapy
  • pelvic abscess
  • pelvic inflammatory disease
  • Tuboovarian abscess
  • tuboovarian complex

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Antibiotic treatment of tuboovarian abscess : Comparison of broad-spectrum β-lactam agents versus clindamycin-containing regimens. / Reed, Susan D.; Landers, Daniel V.; Sweet, Richard L.

In: American Journal of Obstetrics and Gynecology, Vol. 164, No. 6 PART 1, 1991, p. 1556-1562.

Research output: Contribution to journalArticle

@article{52ca62f334ae4fd1875d1d79df20e8a8,
title = "Antibiotic treatment of tuboovarian abscess: Comparison of broad-spectrum β-lactam agents versus clindamycin-containing regimens",
abstract = "One hundred nineteen patients with tuboovarian abscess were evaluated for response to antibiotics. Results were stratified into three groups by antimicrobial regimen. Group 1 consisted of 37 patients treated with a single-agent broad-spectrum intravenous antibiotic and oral doxycycline. Initial clinical response (defined as decreased pain, diminished white blood cell count, or defervescence) in group 1 was 31/37 (84{\%}). Group 2 consisted of 64 patients treated with clindamycin in combination with an aminoglycoside with or without a penicillin. There was an initial clinical response in 45 of 64 (70{\%}). Group 3 consisted of 18 patients from group 1 who were changed to a clindamycin-containing regimen after 2 to 3 days of initial treatment with a single-agent broad-spectrum antibiotic. The decision to switch antibiotics was not based on treatment failure but occurred when delayed ultrasonography confirmed the diagnosis of tuboovarian abscess. The switch reflected physician preference for clindamycin-containing regimens in the treatment of tuboovarian abscesses. The response rate in this subset of patients was 14 of 18 (78{\%}). Overall initial clinical response rate was 90 of 119 (75{\%}). There were no statistically significant demographic or clinical differences among the three groups. There was no statistical difference in the rate of early and late antibiotic failure rates among the groups. Our study demonstrates that extended-spectrum antibiotic coverage, including single-agent broad-spectrum antibiotics such as cefoxitin, in conjunction with doxycycline has efficacy that is equivalent to that of clindamycin-containing regimens. An overall medical treatment success rate of 75{\%} suggests that conservative treatment of tuboovarlan abscesses is warranted.",
keywords = "antimicrobial therapy, pelvic abscess, pelvic inflammatory disease, Tuboovarian abscess, tuboovarian complex",
author = "Reed, {Susan D.} and Landers, {Daniel V.} and Sweet, {Richard L}",
year = "1991",
doi = "10.1016/0002-9378(91)91436-Z",
language = "English (US)",
volume = "164",
pages = "1556--1562",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "6 PART 1",

}

TY - JOUR

T1 - Antibiotic treatment of tuboovarian abscess

T2 - Comparison of broad-spectrum β-lactam agents versus clindamycin-containing regimens

AU - Reed, Susan D.

AU - Landers, Daniel V.

AU - Sweet, Richard L

PY - 1991

Y1 - 1991

N2 - One hundred nineteen patients with tuboovarian abscess were evaluated for response to antibiotics. Results were stratified into three groups by antimicrobial regimen. Group 1 consisted of 37 patients treated with a single-agent broad-spectrum intravenous antibiotic and oral doxycycline. Initial clinical response (defined as decreased pain, diminished white blood cell count, or defervescence) in group 1 was 31/37 (84%). Group 2 consisted of 64 patients treated with clindamycin in combination with an aminoglycoside with or without a penicillin. There was an initial clinical response in 45 of 64 (70%). Group 3 consisted of 18 patients from group 1 who were changed to a clindamycin-containing regimen after 2 to 3 days of initial treatment with a single-agent broad-spectrum antibiotic. The decision to switch antibiotics was not based on treatment failure but occurred when delayed ultrasonography confirmed the diagnosis of tuboovarian abscess. The switch reflected physician preference for clindamycin-containing regimens in the treatment of tuboovarian abscesses. The response rate in this subset of patients was 14 of 18 (78%). Overall initial clinical response rate was 90 of 119 (75%). There were no statistically significant demographic or clinical differences among the three groups. There was no statistical difference in the rate of early and late antibiotic failure rates among the groups. Our study demonstrates that extended-spectrum antibiotic coverage, including single-agent broad-spectrum antibiotics such as cefoxitin, in conjunction with doxycycline has efficacy that is equivalent to that of clindamycin-containing regimens. An overall medical treatment success rate of 75% suggests that conservative treatment of tuboovarlan abscesses is warranted.

AB - One hundred nineteen patients with tuboovarian abscess were evaluated for response to antibiotics. Results were stratified into three groups by antimicrobial regimen. Group 1 consisted of 37 patients treated with a single-agent broad-spectrum intravenous antibiotic and oral doxycycline. Initial clinical response (defined as decreased pain, diminished white blood cell count, or defervescence) in group 1 was 31/37 (84%). Group 2 consisted of 64 patients treated with clindamycin in combination with an aminoglycoside with or without a penicillin. There was an initial clinical response in 45 of 64 (70%). Group 3 consisted of 18 patients from group 1 who were changed to a clindamycin-containing regimen after 2 to 3 days of initial treatment with a single-agent broad-spectrum antibiotic. The decision to switch antibiotics was not based on treatment failure but occurred when delayed ultrasonography confirmed the diagnosis of tuboovarian abscess. The switch reflected physician preference for clindamycin-containing regimens in the treatment of tuboovarian abscesses. The response rate in this subset of patients was 14 of 18 (78%). Overall initial clinical response rate was 90 of 119 (75%). There were no statistically significant demographic or clinical differences among the three groups. There was no statistical difference in the rate of early and late antibiotic failure rates among the groups. Our study demonstrates that extended-spectrum antibiotic coverage, including single-agent broad-spectrum antibiotics such as cefoxitin, in conjunction with doxycycline has efficacy that is equivalent to that of clindamycin-containing regimens. An overall medical treatment success rate of 75% suggests that conservative treatment of tuboovarlan abscesses is warranted.

KW - antimicrobial therapy

KW - pelvic abscess

KW - pelvic inflammatory disease

KW - Tuboovarian abscess

KW - tuboovarian complex

UR - http://www.scopus.com/inward/record.url?scp=0025765228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025765228&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(91)91436-Z

DO - 10.1016/0002-9378(91)91436-Z

M3 - Article

VL - 164

SP - 1556

EP - 1562

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 6 PART 1

ER -